ARCOMA.ST Intrinsic
Value
As of 2024-12-13, the Intrinsic Value of Arcoma AB (ARCOMA.ST) is
30.40 SEK. This ARCOMA.ST valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 10.45 SEK, the upside of Arcoma AB is
190.90%.
The range of the Intrinsic Value is 16.64 - 252.09 SEK
30.40 SEK
Intrinsic Value
ARCOMA.ST Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
16.64 - 252.09 |
30.40 |
190.9% |
| DCF (Growth 10y) |
26.51 - 392.89 |
48.00 |
359.3% |
| DCF (EBITDA 5y) |
14.80 - 26.22 |
19.54 |
87.0% |
| DCF (EBITDA 10y) |
21.78 - 39.26 |
28.89 |
176.4% |
| Fair Value |
4.92 - 4.92 |
4.92 |
-52.90% |
| P/E |
6.16 - 28.57 |
15.57 |
49.0% |
| EV/EBITDA |
10.06 - 24.20 |
15.01 |
43.7% |
| EPV |
22.68 - 32.36 |
27.52 |
163.4% |
| DDM - Stable |
17.27 - 313.50 |
165.39 |
1482.6% |
| DDM - Multi |
18.30 - 258.42 |
34.19 |
227.1% |
ARCOMA.ST Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
137.79 |
| Beta |
0.66 |
| Outstanding shares (mil) |
13.19 |
| Enterprise Value (mil) |
127.10 |
| Market risk premium |
5.10% |
| Cost of Equity |
5.52% |
| Cost of Debt |
6.99% |
| WACC |
5.53% |